AR036680A1 - Procedimiento para preparar derivados de heterocicloalquilsulfonilpirazol y compuestos utiles en su preparacion - Google Patents
Procedimiento para preparar derivados de heterocicloalquilsulfonilpirazol y compuestos utiles en su preparacionInfo
- Publication number
- AR036680A1 AR036680A1 ARP020103634A ARP020103634A AR036680A1 AR 036680 A1 AR036680 A1 AR 036680A1 AR P020103634 A ARP020103634 A AR P020103634A AR P020103634 A ARP020103634 A AR P020103634A AR 036680 A1 AR036680 A1 AR 036680A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- formula
- halo
- amino
- optionally substituted
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 9
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- -1 cyano, mercapto Chemical class 0.000 abstract 3
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 abstract 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 125000001188 haloalkyl group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000004967 formylalkyl group Chemical group 0.000 abstract 1
- 230000000116 mitigating effect Effects 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Un procedimiento para preparar un compuesto de la fórmula (1) que comprende la combinación de: (a) un compuesto de la fórmula (2); (b) un compuesto de la fórmula (3); (c) uno o más ácidos; (d) uno o más disolventes orgánicos miscibles en agua; y (e) agua; en la que: R1 es fenilo opcionalmente sustituido por 1-3 sustituyentes independientemente seleccionados del grupo formado por: halo-hidroxilo, ciano, mercapto, alquilo C1-6, alquenilo C2-6, alcoxi C1-6, -OCF3, alquilo C1-6-S-, alquilo C1-6-S(=O)-, alquilo C1-6-SO2-, amino, alquilamino C1-6, di[alquil C1-6]amino, H2N-(C=O)-, alquil C1-6-NH-(C=O)- y formilo; R2 es hidrógeno, halo- ó alquilo C1-6; R3 alquilo C1-6 opcionalmente sustituido por uno a tres haloátomos; y R4 es alquilo C1-6. Se describen también compuestos de fórmula (4) en el que R1 es fenilo opcionalmente sustituido por 1-3 sustituyentes independientemente seleccionados del grupo formado por: halo-hidroxilo, ciano, mercapto, alquilo C1-6, alquenilo C2-6, alcoxi C1-6, -OCF3, alquilo C1-6-S-, alquilo C1-6-S(=O)-, alquilo C1-6-SO2-, amino, alquilamino C1-6, di[alquil C1-6]amino, H2N-(C=O)-, alquil C1-6-NH-(C=O)- y formilo; R2 es hidrógeno, halo- ó alquilo C1-6; R3 es alquilo C1-6 opcionalmente sustituido por uno a tres haloátomos; y R4 es alquilo C1-6, útiles en la fabricación de los mismos. Los compuestos de fórmula (1) son útiles en el tratamiento o mitigación de la inflamación y otros trastornos asociados con la inflamación.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32564701P | 2001-09-28 | 2001-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR036680A1 true AR036680A1 (es) | 2004-09-29 |
Family
ID=23268786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020103634A AR036680A1 (es) | 2001-09-28 | 2002-09-26 | Procedimiento para preparar derivados de heterocicloalquilsulfonilpirazol y compuestos utiles en su preparacion |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6646128B2 (es) |
| EP (1) | EP1430046A1 (es) |
| JP (1) | JP2005504127A (es) |
| KR (1) | KR20040039424A (es) |
| CN (1) | CN1561339A (es) |
| AR (1) | AR036680A1 (es) |
| BR (1) | BR0212860A (es) |
| CA (1) | CA2457798A1 (es) |
| CZ (1) | CZ2004414A3 (es) |
| GT (1) | GT200200183A (es) |
| HU (1) | HUP0401914A3 (es) |
| IL (1) | IL160369A0 (es) |
| MX (1) | MXPA04002879A (es) |
| PA (1) | PA8555601A1 (es) |
| PE (1) | PE20030532A1 (es) |
| PL (1) | PL370110A1 (es) |
| RU (1) | RU2004109148A (es) |
| UY (1) | UY27453A1 (es) |
| WO (1) | WO2003029244A1 (es) |
| ZA (1) | ZA200401043B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008534505A (ja) * | 2005-03-25 | 2008-08-28 | メルク エンド カムパニー インコーポレーテッド | テストステロンサプリメントおよび５アルファ−レダクターゼインヒビターによる男性の治療方法 |
| JP5519500B2 (ja) * | 2007-07-23 | 2014-06-11 | ザ チャイニーズ ユニバーシティー オブ ホンコン | 核酸配列の不均衡性の決定 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH27357A (en) | 1989-09-22 | 1993-06-21 | Fujisawa Pharmaceutical Co | Pyrazole derivatives and pharmaceutical compositions comprising the same |
| IL104311A (en) | 1992-02-05 | 1997-07-13 | Fujisawa Pharmaceutical Co | Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
| US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| CA2276946A1 (en) | 1993-11-30 | 1995-06-08 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides and pharmaceutical compositions containing the same |
| US5475018A (en) | 1993-11-30 | 1995-12-12 | G. D. Searle & Co. | 1,5-diphenyl pyrazole compounds for treatment of inflammation |
| US5401765A (en) | 1993-11-30 | 1995-03-28 | G. D. Searle | 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders |
| US5434178A (en) | 1993-11-30 | 1995-07-18 | G.D. Searle & Co. | 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation |
| CA2195847A1 (en) | 1994-07-27 | 1996-02-08 | John J. Talley | Substituted thiazoles for the treatment of inflammation |
| US5620999A (en) | 1994-07-28 | 1997-04-15 | Weier; Richard M. | Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation |
| US5585504A (en) | 1994-09-16 | 1996-12-17 | Merck & Co., Inc. | Process of making cox-2 inhibitors having a lactone bridge |
| JPH10511089A (ja) | 1994-12-21 | 1998-10-27 | メルク フロスト カナダ インコーポレーテツド | Ｃｏｘ−２阻害剤としてのジアリール−２−（５ｈ）−フラノン |
| US5691374A (en) | 1995-05-18 | 1997-11-25 | Merck Frosst Canada Inc. | Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors |
| US5756529A (en) | 1995-09-29 | 1998-05-26 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies |
| GB9520584D0 (en) | 1995-10-09 | 1995-12-13 | Fujisawa Pharmaceutical Co | Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same |
| UA57002C2 (uk) | 1995-10-13 | 2003-06-16 | Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі. | Похідне (метилсульфоніл)феніл-2-(5н)-фуранону, фармацевтична композиція та спосіб лікування |
| WO1997016435A1 (en) | 1995-10-30 | 1997-05-09 | Merck Frosst Canada Inc. | 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors |
| PT1104758E (pt) | 1999-12-03 | 2003-12-31 | Pfizer Prod Inc | Derivados de acetileno como agentes anti-inflamatorios/analgesicos |
| DE60006057T2 (de) | 1999-12-03 | 2004-05-27 | Pfizer Products Inc., Groton | Heteroarylphenylpyrazolverbindungen zur Verwendung als analgetisches/entzündungshemmendes Mittel |
| DZ3246A1 (fr) | 1999-12-03 | 2001-06-07 | Pfizer Prod Inc | Dérivé heterocyclo-alkylsulfonyle pyrazole en tant qu'agents anti-inflammatoires/analgesiques |
-
2002
- 2002-09-12 GT GT200200183A patent/GT200200183A/es unknown
- 2002-09-19 IL IL16036902A patent/IL160369A0/xx unknown
- 2002-09-19 RU RU2004109148/04A patent/RU2004109148A/ru not_active Application Discontinuation
- 2002-09-19 MX MXPA04002879A patent/MXPA04002879A/es unknown
- 2002-09-19 BR BR0212860-8A patent/BR0212860A/pt not_active IP Right Cessation
- 2002-09-19 WO PCT/IB2002/003908 patent/WO2003029244A1/en not_active Ceased
- 2002-09-19 HU HU0401914A patent/HUP0401914A3/hu unknown
- 2002-09-19 KR KR10-2004-7004437A patent/KR20040039424A/ko not_active Ceased
- 2002-09-19 EP EP02760508A patent/EP1430046A1/en not_active Withdrawn
- 2002-09-19 PL PL02370110A patent/PL370110A1/xx not_active Application Discontinuation
- 2002-09-19 CN CNA028191625A patent/CN1561339A/zh active Pending
- 2002-09-19 CZ CZ2004414A patent/CZ2004414A3/cs unknown
- 2002-09-19 CA CA002457798A patent/CA2457798A1/en not_active Abandoned
- 2002-09-19 JP JP2003532493A patent/JP2005504127A/ja active Pending
- 2002-09-25 UY UY27453A patent/UY27453A1/es not_active Application Discontinuation
- 2002-09-26 AR ARP020103634A patent/AR036680A1/es unknown
- 2002-09-26 PE PE2002000951A patent/PE20030532A1/es not_active Application Discontinuation
- 2002-09-27 PA PA20028555601A patent/PA8555601A1/es unknown
- 2002-09-27 US US10/256,432 patent/US6646128B2/en not_active Expired - Fee Related
-
2003
- 2003-08-25 US US10/648,588 patent/US6846930B2/en not_active Expired - Fee Related
-
2004
- 2004-02-09 ZA ZA200401043A patent/ZA200401043B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0212860A (pt) | 2004-10-13 |
| US20030100765A1 (en) | 2003-05-29 |
| MXPA04002879A (es) | 2004-07-15 |
| GT200200183A (es) | 2003-05-23 |
| PE20030532A1 (es) | 2003-06-18 |
| RU2004109148A (ru) | 2005-08-20 |
| WO2003029244A1 (en) | 2003-04-10 |
| US20040044042A1 (en) | 2004-03-04 |
| JP2005504127A (ja) | 2005-02-10 |
| KR20040039424A (ko) | 2004-05-10 |
| CA2457798A1 (en) | 2003-04-10 |
| HUP0401914A2 (hu) | 2005-01-28 |
| EP1430046A1 (en) | 2004-06-23 |
| IL160369A0 (en) | 2004-07-25 |
| HUP0401914A3 (en) | 2006-04-28 |
| PA8555601A1 (es) | 2003-09-17 |
| UY27453A1 (es) | 2003-04-30 |
| WO2003029244A8 (en) | 2003-09-04 |
| US6646128B2 (en) | 2003-11-11 |
| CZ2004414A3 (cs) | 2004-12-15 |
| US6846930B2 (en) | 2005-01-25 |
| CN1561339A (zh) | 2005-01-05 |
| PL370110A1 (en) | 2005-05-16 |
| ZA200401043B (en) | 2005-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0206433A (pt) | Composto, composição farmacêutica, processo para a prepapação de um composto, e, uso de um composto | |
| CR20110380A (es) | Derivados de pirimidina para el tratamiento del crecimiento celular anormal (divisional exp. 8266) | |
| ATE476173T1 (de) | Photostabile organische sonnenschutzmittel mit antioxidativen eigenschaften | |
| UY27503A1 (es) | Nuevos derivados de piperazina | |
| ECSP034917A (es) | Nuevos derivados de acido sulfonico | |
| ES8707925A1 (es) | Un procedimiento para la preparacion de derivados de aminofenol | |
| PA8589801A1 (es) | Aminoalcoxiindoles | |
| AR047531A1 (es) | Derivados 1h-tieno(2,3-c)pirazol utiles como inhibidores de quinasa | |
| BRPI0411308A (pt) | composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto | |
| ES2054502T3 (es) | Esteres del acido 10-(1-hidroxietil)-11-oxo-1-azatriciclo(7.2.0.0(3.8))-undec-2-en-2-carboxilico y un procedimiento para su preparacion. | |
| AR036680A1 (es) | Procedimiento para preparar derivados de heterocicloalquilsulfonilpirazol y compuestos utiles en su preparacion | |
| AR031808A1 (es) | 2-piridonas antimicrobianas, sus composiciones y usos | |
| CY1107481T1 (el) | Εναντιοεκλεκτικη αλκυλιωση τρικυκλικων ενωσεων | |
| DE69820481D1 (de) | Verfahren zur herstellung von cholecalciferol-derivaten und zwischenverbindungen | |
| BRPI0206922B8 (pt) | composto de fragrância, composição de fragrância contendo o mesmo, e método para preparação de um composto de fragrância | |
| AR007291A1 (es) | Nuevos derivados de 10,11-dihidro-10-oxo-5h-dibenz/b, f/azepina-5-carboxamida, metodo de preparacion y su uso en la preparacion de una composicion farmaceutica | |
| PT1317455E (pt) | Processo para a preparacao de um composto de imidazopiridina substituido | |
| ES2183500T3 (es) | Nuevos compuestos y composiciones farmaceuticas que los contienen. | |
| AR026453A1 (es) | Procedimiento para la preparacion de cetiminas | |
| EA200500028A1 (ru) | Новые соединения 3-(4-оксо-4h-хромен-2-ил)-(1h)-хинолин-4-она, способ их получения и фармацевтические композиции, которые их содержат | |
| PE20040693A1 (es) | N-sulfonilaminotiazol como mediadores de la sulfatasa de esteroides | |
| PE20030154A1 (es) | Eurotinona y derivados de la misma, procedimiento para su preparacion | |
| BR0201312A (pt) | Compostos de pirimidin-4-ona, processo para sua preparação e composições farmacêuticas contendo os referidos | |
| NO20062761L (no) | Ny fremgangsmate for fremstilling av 3-fluorinterte quinoliner | |
| NO20022690L (no) | Nye strukturelle analoger av Vitamin D |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |